Herantis taps Indivi for digital biomarker tech in Parkinson’s disease trial
Finnish biotech Herantis Pharma is teaming up with Swiss medtech Indivi to help seek early detection of Parkinson’s disease in a new proof-of-concept clinical t...
Finnish biotech Herantis Pharma is teaming up with Swiss medtech Indivi to help seek early detection of Parkinson’s disease in a new proof-of-concept clinical trial.